Cargando…
Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions
Treatment of children and adolescents with juvenile idiopathic arthritis and other pediatric rheumatic diseases has evolved. Where once there was only a limited arsenal of medications, with significant side effects and inadequate efficacy, today, with an increased understanding of the pathogenesis o...
Autor principal: | Marzan, Katherine Anne B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916012/ https://www.ncbi.nlm.nih.gov/pubmed/24600289 http://dx.doi.org/10.2147/AHMT.S22607 |
Ejemplares similares
-
Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
por: Poddighe, Dimitri, et al.
Publicado: (2022) -
Non-Rheumatic Chronic Comorbidities in Children with Juvenile Idiopathic Arthritis
por: Haşlak, Fatih, et al.
Publicado: (2023) -
Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008) -
Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014) -
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)